Ose Immunotherapeutics
Clinical trials sponsored by Ose Immunotherapeutics, explained in plain language.
-
New immune drug OSE-279 takes on advanced tumors
Disease control Recruiting nowThis study tests a new drug called OSE-279 that helps the immune system fight cancer. It is for people with advanced solid tumors or lymphomas that have not responded to other treatments. The trial has three parts: finding the right dose, checking safety, and measuring how well t…
Phase: PHASE1, PHASE2 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 13:03 UTC
-
New vaccine aims to outsmart Drug-Resistant lung cancer
Disease control Recruiting nowThis Phase 3 trial tests a cancer vaccine called OSE2101 against standard chemotherapy (docetaxel) in 363 people with advanced non-small cell lung cancer that has stopped responding to immunotherapy. The vaccine targets multiple proteins found on cancer cells to help the immune s…
Phase: PHASE3 • Sponsor: OSE Immunotherapeutics • Aim: Disease control
Last updated Jun 27, 2026 12:02 UTC